作者单位:
Haartman Institute, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
[1]
Karolinska Institutet, Department of Medicine/Solna, Unit for Infectious Diseases, Stockholm, Sweden.
[2]
Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
[3]
Karolinska Institutet, Department of Medicine/Solna, Unit for Infectious Diseases, Stockholm, Sweden; Centre for Clinical Research, Sörmland County Council, Eskilstuna, Sweden.
[4]
Aava Travel Clinic, Aava Medical Centre, Helsinki, Finland.
[5]
Swedish Institute for Communicable Disease Control, Solna, Sweden.
[6]
Karolinska Institutet, Department of Medicine/Huddinge, Unit for Infectious Diseases, Stockholm, Sweden.
[7]
Haartman Institute, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUSLAB, Division of Virology and Immunology, Helsinki University Central Hospital, Helsinki, Finland; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
[8]
Haartman Institute, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland; Aava Travel Clinic, Aava Medical Centre, Helsinki, Finland; Department of Medicine, University of Helsinki, Helsinki, Finland. Electronic address: anu.kantele@hus.fi.
[9]
主题词
成年人(Adult);老年人(Aged);抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);交叉保护(Cross Protection);脑炎病毒, 日本(Encephalitis Virus, Japanese);脑炎, 日本(Encephalitis, Japanese);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);免疫接种, 加强(Immunization, Secondary);日本脑炎疫苗(Japanese Encephalitis Vaccines);男(雄)性(Male);中年人(Middle Aged);旅行医学(Travel Medicine);接种(Vaccination);青年人(Young Adult)
DOI
10.1016/j.vaccine.2013.10.055
PMID
24176496
发布时间
2013-12-16